Cargando…
Mitochondrial therapy for doxorubicin cardiomyopathy: nuclear factor-κB to the rescue?
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177477/ https://www.ncbi.nlm.nih.gov/pubmed/31868877 http://dx.doi.org/10.1093/cvr/cvz344 |
_version_ | 1783525228864864256 |
---|---|
author | Nijholt, Kirsten Theresa Westenbrink, Berend Daan de Boer, Rudolf Allert |
author_facet | Nijholt, Kirsten Theresa Westenbrink, Berend Daan de Boer, Rudolf Allert |
author_sort | Nijholt, Kirsten Theresa |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7177477 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-71774772020-04-28 Mitochondrial therapy for doxorubicin cardiomyopathy: nuclear factor-κB to the rescue? Nijholt, Kirsten Theresa Westenbrink, Berend Daan de Boer, Rudolf Allert Cardiovasc Res Editorials Oxford University Press 2020-05-01 2019-12-23 /pmc/articles/PMC7177477/ /pubmed/31868877 http://dx.doi.org/10.1093/cvr/cvz344 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Editorials Nijholt, Kirsten Theresa Westenbrink, Berend Daan de Boer, Rudolf Allert Mitochondrial therapy for doxorubicin cardiomyopathy: nuclear factor-κB to the rescue? |
title | Mitochondrial therapy for doxorubicin cardiomyopathy: nuclear factor-κB to the rescue? |
title_full | Mitochondrial therapy for doxorubicin cardiomyopathy: nuclear factor-κB to the rescue? |
title_fullStr | Mitochondrial therapy for doxorubicin cardiomyopathy: nuclear factor-κB to the rescue? |
title_full_unstemmed | Mitochondrial therapy for doxorubicin cardiomyopathy: nuclear factor-κB to the rescue? |
title_short | Mitochondrial therapy for doxorubicin cardiomyopathy: nuclear factor-κB to the rescue? |
title_sort | mitochondrial therapy for doxorubicin cardiomyopathy: nuclear factor-κb to the rescue? |
topic | Editorials |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177477/ https://www.ncbi.nlm.nih.gov/pubmed/31868877 http://dx.doi.org/10.1093/cvr/cvz344 |
work_keys_str_mv | AT nijholtkirstentheresa mitochondrialtherapyfordoxorubicincardiomyopathynuclearfactorkbtotherescue AT westenbrinkberenddaan mitochondrialtherapyfordoxorubicincardiomyopathynuclearfactorkbtotherescue AT deboerrudolfallert mitochondrialtherapyfordoxorubicincardiomyopathynuclearfactorkbtotherescue |